Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (2432)	10/21/1997 10:57:00 AM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

Does anyone know if the 300 million speculated in '98 sales by AGPH includes estimates on European sales? Thanks. sf

To: Henry Niman who wrote (2432)	10/21/1997 5:11:00 PM
From: JOHN W.	Respond to of 6136

Judy if you bought AGPH today, you will be very happy. P.S.: Henry you the street.com link that you insist on advertising on this thread had a very interesting para: " However, the future of diabetes treatment, as in cancer and AIDS, may be in cocktail therapy, meaning that pramlintide may be useful in combination with other drugs" Your drug is not the miracle cure either. With such good news and on a day like this, are you disappointed in the response? Have you ever had any voice communications with the street.com?